Delivery Order SPE2DB22D2206-SPE2DB24FHG89
- Not listed
- This federal contract award is for the delivery of PROMETRIUM 200 MG CAPSULE 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The $5,147.57 firm fixed-price delivery order was awarded on May 1, 2024, with a completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of PROMETRIUM 200 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,561.03 and an ultimate completion date of February 1, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $2,506.41, is for the provision of PROMETRIUM 200 MG CAPSULE 30S, a pharmaceutical product. The contract has a performance period through January 30, 2024. AmerisourceBergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,415.20, is for the delivery of PROMETRIUM 100 MG CAPSULE 30S and has a completion date of December 13, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order for the supply of PROMETRIUM 100 MG CAPSULE 30S to the Defense Logistics Agency (DLA). The $11,061.03 firm fixed-price contract has a completion date of November 12, 2024. The award is not associated with a set-aside program and is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $5,529.93 firm fixed-price delivery order contract is for the supply of PROMETRIUM 200 MG CAPSULE 30S, a pharmaceutical product, with a performance period ending on March 7, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
- This federal contract award is for the delivery of PROMETRIUM 200 MG CAPSULE 30S medical supplies. The contract, valued at $19,258.54, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,473.61 firm fixed price delivery order is for the supply of PROMETRIUM 200 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of July 11, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,363.54 Firm Fixed Price delivery order provides PROMETRIUM 100 MG CAPSULE 30S, a pharmaceutical product, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide PROMETRIUM 200 MG CAPSULE 30S for $14,029.94. The contract has a completion date of December 21, 2023 and was awarded on December 20, 2023. Amerisourcebergen Drug Corp has received multiple federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related distribution...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHG89Delivery Order
This federal contract award is for the delivery of PROMETRIUM 100 MG CAPSULE 30S to the Defense Logistics Agency (DLA), a defense agency. The $1,484.61 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, the prime contractor, on May 20, 2024, with a completion date of May 21, 2024. The contract has no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The company has significant experience providing a wide range of pharmaceutical products and medical supplies to the U.S. federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 5/20/24 |